Pergolide Remains Treatment of Choice for PPID

Pituitary pars intermedia dysfunction (PPID), often called equine Cushing's disease, has been treated with the drug pergolide for years. The main reason pergolide was initially the treatment of choice was largely based on the drug's effectiveness in treating people with Parkinson's disease, a human endocrine disorder, according to Ronette Gehring, BVSc, MMedVet (Pharm), MRCVS, Dipl. ACVCP,

To continue reading this article, become a member of TheHorse.com.

It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.